AA Multiple randomized trials or meta-analyses, consistent results. How we grade →RCT · 3,234 adults with raised glucose, mean age 51
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
Diabetes Prevention Program Research Group. New England Journal of Medicine. 2002.
- In plain language
- Metformin 850 mg twice a day cut new diabetes by 31% and a lifestyle program by 58% versus placebo over about 2.8 years.
- Limits
- People at high risk of diabetes, not healthy adults; diabetes, not aging, was the outcome.
- Which of our grades it feeds
- DD Mostly mechanistic or early data. Shown openly. How we grade →Science summary: Metformin as an aging drug: what the evidence shows, and why the TAME trial has not started
- Source
- doi.org/10.1056/NEJMoa012512 · PubMed 11832527 · Free full text
Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.